AstraZeneca Pharma Q3 net up 84 pc to Rs 16 crore
The company had reported a net profit of Rs 8.67 crore in October-December quarter a year ago, AstraZeneca Pharma said
By PTI |
Agencies
NEW DELHI: Drug firm AstraZeneca Pharma today reported an 84.08 per cent increase in its standalone net profit at Rs 15.96 crore for the third quarter ended December.
The company had reported a net profit of Rs 8.67 crore in October-December quarter a year ago, AstraZeneca Pharma said in a BSE filing.
Its total income from operations was up 3.94 per cent to Rs 150.28 crore during the quarter under review as against Rs 144.58 crore earlier.
AstraZeneca's overall expenses were up 1.44 per cent to Rs 139.36 crore as against Rs 137.38 crore in the corresponding period of last fiscal.
Shares of AstraZeneca today settled at Rs 948.70 on BSE, up 1.02 per cent from the previous close.
The company had reported a net profit of Rs 8.67 crore in October-December quarter a year ago, AstraZeneca Pharma said in a BSE filing.
Its total income from operations was up 3.94 per cent to Rs 150.28 crore during the quarter under review as against Rs 144.58 crore earlier.
AstraZeneca's overall expenses were up 1.44 per cent to Rs 139.36 crore as against Rs 137.38 crore in the corresponding period of last fiscal.
Shares of AstraZeneca today settled at Rs 948.70 on BSE, up 1.02 per cent from the previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerADVERTISEMENT
